These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38085840)

  • 1. May
    He J; Li P; Zhang S
    Hell J Nucl Med; 2023; 26(3):226-227. PubMed ID: 38085840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of
    Sayiner ZA; Elboğa U; Sahin E; Ozturk S; Cayirli YB; Celen YZ; Akarsu E; Dogan I; Kilbas B; Eryilmaz K; Cakici D
    Hell J Nucl Med; 2023; 26(1):41-46. PubMed ID: 37115220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
    Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
    Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Shangguan C; Yang C; Shi Z; Miao Y; Hai W; Shen Y; Qu Q; Li B; Mi J
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):285-294. PubMed ID: 37634891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FAPI Compared with FDG PET/CT for Diagnosis of Primary and Metastatic Lung Cancer.
    Wei Y; Ma L; Li P; Lu J; Ren J; Yan S; Wu H; Yuan S; Fu Z; Yu J
    Radiology; 2023 Aug; 308(2):e222785. PubMed ID: 37552075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 68 Ga-FAPI-04 and fluorine-18-fluorodeoxyglucose PET/computed tomography in the detection of ovarian malignancies.
    Zheng W; Liu L; Feng Y; Wang L; Chen Y
    Nucl Med Commun; 2023 Mar; 44(3):194-203. PubMed ID: 36472415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superiority of [
    Fu L; Huang S; Wu H; Dong Y; Xie F; Wu R; Zhou K; Tang G; Zhou W
    Eur Radiol; 2022 Sep; 32(9):6281-6290. PubMed ID: 35380229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18 F-FDG PET/CT.
    Dong Y; Sun P; Wu H; Zhong J; Cao M; Tang G; Zhou W
    Nucl Med Commun; 2023 Nov; 44(11):1011-1019. PubMed ID: 37661771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of
    Güzel Y; Kaplan İ
    Hell J Nucl Med; 2023; 26(1):26-34. PubMed ID: 37031420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Head-to-Head Comparison of [
    Wegen S; van Heek L; Linde P; Claus K; Akuamoa-Boateng D; Baues C; Sharma SJ; Schomäcker K; Fischer T; Roth KS; Klußmann JP; Marnitz S; Drzezga A; Kobe C
    Mol Imaging Biol; 2022 Dec; 24(6):986-994. PubMed ID: 35771317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic value of
    Jiao M; Mingsong T; Hao J; Chunyin Z
    Hell J Nucl Med; 2023; 26(2):123-131. PubMed ID: 37527048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
    Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
    Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical prospective study of Gallium 68 (
    Jinghua L; Kui X; Deliang G; Bo L; Qian Z; Haitao W; Yaqun J; Dongde W; Xigang X; Ping J; Shengli T; Zhiyong Y; Yueming H; Zhonglin Z; Yong H; Yufeng Y
    Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2152-2166. PubMed ID: 36809426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast Activation Protein and Glycolysis in Lymphoma Diagnosis: Comparison of
    Chen X; Wang S; Lai Y; Wang G; Wei M; Jin X; Ding J; Zhang Y; Shi Y; Wang F; Zhu H; Yang Z; Wang X
    J Nucl Med; 2023 Sep; 64(9):1399-1405. PubMed ID: 37385675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
    Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the role of 18 F-fluorodeoxyglucose PET/computed tomography and 68 Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
    Güzel Y; Kömek H; Can C; Kaplan İ; Kepenek F; Ebinç S; Büyükdeniz MP; Gündoğan C; Oruç Z
    Nucl Med Commun; 2023 Jul; 44(7):631-639. PubMed ID: 37114422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of [
    Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of
    Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
    Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.